-
EU asks India for 10 million AstraZeneca vaccines to meet shortfall
expresspharma
April 02, 2021
Any quick approval of the EU request is unlikely, however, with India scrambling to expand its own domestic vaccination drive, said a Indian government official.
-
EU approval for new AI technology that can predict heart attacks
pharmatimes
March 31, 2021
New artificial intelligence (AI) technology that can identify if people are at high risk of having a fatal heart attack before it occurs has been approved in the EU.
-
EU warns about tougher export control of COVID vaccines as internal feuds intensify
expresspharma
March 19, 2021
The European Commission threatened to ban COVID-19 vaccine exports to countries like Britain that have higher vaccination rates but do not export shots to the EU, as rifts over the scarcity of the shots deepened and the 27-nation bloc struggled to ...
-
EU countries suspend use of Covid-19 vaccine AstraZeneca
pharmaceutical-technology
March 16, 2021
Several countries in Europe have suspended the University of Oxford / AstraZeneca (AZ) Covid-19 vaccine completely or partially after several suspected deaths were reported due to blood clotting following vaccination.
-
UK denies EU accusations of Covid-19 vaccine export bans
pharmaceutical-technology
March 11, 2021
The UK and the European Union (EU) are embroiled in a public diplomatic row about Covid-19 vaccine exports.
-
EU regulator advises caution on EUA for Sputnik COVID-19 vaccine
expresspharma
March 09, 2021
Sputnik V has already been approved or is being assessed for approval in three EU member states - Hungary, Slovakia and the Czech Republic.
-
Cosentyx gains EU approval for new label extension
pharmatimes
March 03, 2021
Novartis’ interleukin (IL)-17A inhibitor Cosentyx has gained an EU label update to include data for axial manifestations of psoriatic arthritis (PsA).
-
EU contributes extra €500m to COVAX facility for Covid-19 vaccine supply
pharmaceutical-technology
February 23, 2021
The European Union (EU) doubles its contribution to date by providing an additional €500m for the COVAX Facility, a global initiative for securing fair and equitable access to safe and effective Covid-19 vaccines in low and middle-income countries.
-
Pfizer, BioNTech to Supply EU with 200 Million Additional Doses of COMIRNATY
americanpharmaceuticalreview
February 20, 2021
Pfizer and BioNTech announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states.
-
EU launches vaccine incubator to tackle Covid-19 variant threat
pharmaceutical-technology
February 20, 2021
The European Union (EU) has set up an incubator to help prepare member states against emerging variants of SARS-CoV-2, the virus which causes Covid-19. Covid-19 variants have been emerging across the world, including B117 in the UK and B1351 in ...